Nicholas F. Evageliou

<i>ODC1</i> Is a Critical Determinant of <i>MYCN</i> Oncogenesis and a Therapeutic Target in Neuroblastoma

Michael D. Hogarty, Murray D. Norris, Kimberly Davis et al. · Cancer Research · 2008 · 254 citations · Full text

Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression

Nicholas F. Evageliou, Michelle Haber, Annette Vu et al. · Clinical Cancer Research · 2016 · 79 citations · Full text

Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature

Rebecca L. Ruebner, Lawrence Copelovitch, Nicholas F. Evageliou et al. · Pediatric Nephrology · 2013 · 37 citations

Glomerulonephritis, Urology, Medicine +10

An Usual Presentation of Pneumocystis jirovecii Pneumonia in a Woman Treated With Immune Checkpoint Inhibitor

Stephanie Si, Kelley Erickson, Nicholas F. Evageliou et al. · Journal of Pediatric Hematology/Oncology · 2020 · 13 citations

Usual Presentation, Lymphoid Neoplasia, Pneumocystis Jirovecii Pneumonia +15